Instituform Technologies (INSU) was plunging 22.8% on two pieces of news. The Chesterfield, Mo., construction company was downgraded to sell from hold by Stifel Nicolaus after predicting lower 2007 earnings year over year, citing a lack of growth in the general sewer-pipeline-rehabilitation market. The company will also take a $21 million pretax charge (or 48 cents a share after taxes) in order to exit the tunneling business, most of which will be incurred in the first half of the year. The liquidation value of all related assets is estimated at $20 million, at most. Shares slid $5.90 to $20.00.CuraGen (CRGN) tumbled on word Roche will buy its majority-owned unit 454 Life Sciences. The Branford, Conn., biotech will receive $140 million in cash and up to some $14.9 million in stock options, which pans out at roughly $85 million on a fully diluted basis. The deal should close in the second quarter. Shares were off 77 cents, or 20.1%, to $3.07.
Thursday's Small-Cap Winners & Losers
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.